Opening book details…
About this Medicine article
378OSubgroup analysis of a phase II multicenter trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in unresectable or metastatic melanoma patients by Andtbacka, R H I; Ross, M; Agarwala, S S; Taylor, M; Vetto, J; Neves, R I; Daud, A; Khong, H T; Ungerleider, R S; Tanaka, M; Grossmann, K F is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Andtbacka, R H I; Ross, M; Agarwala, S S; Taylor, M; Vetto, J; Neves, R I; Daud, A; Khong, H T; Ungerleider, R S; Tanaka, M; Grossmann, K F
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)